Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impaired Platelet Reactivity as an Early Biomarker for Sepsis-related Thrombocytopenia

NCT03716310 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT03716310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03716310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impaired Platelet Reactivity as an Early Biomarker for Sepsis-related Thrombocytopenia
Lead sponsor
Università degli Studi di Ferrara
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
August 30, 2018
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disseminated intravascular coagulation, platelet aggregation, sepsis, septic shock, thrombocytopenia